SCIMECA, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.042
EU - Europa 1.257
AS - Asia 1.049
SA - Sud America 171
Continente sconosciuto - Info sul continente non disponibili 33
AF - Africa 31
OC - Oceania 1
Totale 4.584
Nazione #
US - Stati Uniti d'America 1.987
SG - Singapore 357
RU - Federazione Russa 332
CN - Cina 276
UA - Ucraina 182
IT - Italia 166
FI - Finlandia 138
BR - Brasile 120
DE - Germania 114
VN - Vietnam 106
HK - Hong Kong 101
GB - Regno Unito 82
PL - Polonia 62
FR - Francia 59
IE - Irlanda 50
JP - Giappone 47
IN - India 42
BD - Bangladesh 33
CA - Canada 25
SE - Svezia 25
KR - Corea 19
CO - Colombia 16
MX - Messico 14
BE - Belgio 12
AR - Argentina 11
VE - Venezuela 9
IQ - Iraq 8
NL - Olanda 8
PK - Pakistan 8
MY - Malesia 7
ZA - Sudafrica 7
JM - Giamaica 6
PY - Paraguay 6
SC - Seychelles 6
TR - Turchia 6
MA - Marocco 5
UZ - Uzbekistan 5
BG - Bulgaria 4
EC - Ecuador 4
ID - Indonesia 4
LT - Lituania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CR - Costa Rica 3
EG - Egitto 3
ES - Italia 3
KG - Kirghizistan 3
QA - Qatar 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PH - Filippine 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.553
Città #
Ashburn 264
Singapore 232
San Jose 167
Chandler 136
Woodbridge 106
Jacksonville 101
Houston 95
Hong Kong 92
Fairfield 86
Ann Arbor 63
Moscow 57
Santa Clara 55
Frankfurt am Main 54
Wilmington 52
Zgierz 52
Dublin 50
Beijing 49
Los Angeles 48
Tokyo 47
Seattle 40
Council Bluffs 37
Medford 37
Hefei 31
Ho Chi Minh City 31
Nanjing 31
Cambridge 29
Hanoi 26
Princeton 25
Lauterbourg 24
Tulsa 24
New York 22
Seongnam 18
Boardman 16
Palermo 16
Kumar 15
Venice 15
Buffalo 14
Helsinki 14
Milan 14
Des Moines 13
Altamura 12
Atlanta 12
Brussels 12
Nanchang 11
Tianjin 11
Dallas 10
São Paulo 10
Chennai 9
Dearborn 9
Ludwigshafen am Rhein 9
Changsha 8
Charlotte 8
Da Nang 8
Lawrence 8
Phoenix 8
San Diego 8
Shenyang 8
Las Vegas 7
Montreal 7
New Delhi 7
Warsaw 7
Bogotá 6
Brasília 6
Brooklyn 6
Chicago 6
Kuala Lumpur 6
London 6
Manchester 6
Poplar 6
San Francisco 6
San Mateo 6
Auburn Hills 5
Columbus 5
Denver 5
Hebei 5
Orem 5
Saint Petersburg 5
Tashkent 5
Asunción 4
Boston 4
Cardiff 4
Guangzhou 4
Haiphong 4
Lanzhou 4
Ningbo 4
Roubaix 4
San Paolo di Civitate 4
Sofia 4
Thái Nguyên 4
West Chicago 4
Amsterdam 3
Baghdad 3
Baltimore 3
Bishkek 3
Biên Hòa 3
Campinas 3
Can Tho 3
Central District 3
Cincinnati 3
City of London 3
Totale 2.660
Nome #
Incidence of Crohn's disease and Card 15 mutation in a small township in Sicily 289
EFFICACY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF SYMPTOMATIC INTESTINAL CROHN'S DISEASE STRICTURES 227
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 222
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. 211
MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 206
Calprotectin in the prediction of endoscopic post-surgical recurrence in CD 204
Clinical course of ulcerative colitis 200
Infliximab in the treatment of Crohn's disease :predictors of response in an Italian multicenter open study 199
THE ROLE OF CARD15 MUTATIONS AND SMOKING IN THE COURSE OF DISEASE IN A MEDITERRANEAN AREA 197
Long term follow-up in an incident cohort of 583 pts with CD 186
The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound 182
Infliximab in moderate to severe sateroid dipendent or refractory severe ulcerative colitis:short term results of 21 case treated 173
Ultrasound in Crohn's disease 169
a meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative maintenance therapy in Crohn's disease 166
efficacy and safety of endoscopic ballon dilatation of symptomatic gastrointestinal Crohn's disease strictures 165
The role of NOD2/CARD15 mutation and smoking in the course of Crohn's disease in a Mediterranean area 163
Le malattie infiammatorie dell'intestino 158
NOD2/CARD15 FREQUENCY IN CROHN'DISEASE IN SICILY:AN EPIDEMIOLOGICAL STUDY 157
Infliximab in the treatment of steroid resistant dependant and fistulating crohn's disease:an analysis of predictors of response in an italian multicenter open study in 573 pts 156
Occul Hepatitis B and infliximab induced HBV reactivation 151
a metaregression analysis of the placebo rates of remission and response in clinical trials of biological therapies in active crohn's disease 148
Salycilate in the prevention of post-surgical recurrence in Crohn's disease 145
Il decorso clinico della colite ulcerosa 142
Come limitare la tossicità dell'infliximab 130
The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defense 121
Infliximab in the treatment of steroid resistant dependant and fistulating crohn's disease:an analysis of predictors of response in an italian multicenter open study in 573 pts 117
Totale 4.584
Categoria #
all - tutte 14.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022132 0 0 0 6 2 6 8 8 25 25 8 44
2022/2023311 27 46 6 34 47 48 6 33 46 1 16 1
2023/2024113 9 36 5 7 9 22 9 2 0 3 0 11
2024/2025427 5 30 22 39 11 27 20 24 36 39 53 121
2025/20261.875 129 60 115 186 193 275 180 209 98 323 65 42
2026/2027353 75 49 192 37 0 0 0 0 0 0 0 0
Totale 4.584